Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Heerspink HJL, Stefnsson BV, Correa-Rotter R, et al
Potential side effects and contraindications should be reviewed with a licensed healthcare provider before starting treatment
Tirzepatide is approved as Mounjaro for diabetes and Zepbound for obesity
Link: Wilding, J
Upload your prior prescription to your portal and schedule a clinician appointment to confirm the right starting dose
However, this evidence is limited, inconsistent, and does not demonstrate clinically significant effects comparable to prescription GLP-1 agonists
US$ 26.94
US$ 22.63
US$ 26.64
US$ 23.40
US$ 26.99
